Impaired inhibition of NF-κB activity by melanoma-associated p16INK4a mutations

This publication has 26 references indexed in Scilit:

• Comparative Expression of NFκB Proteins in Melanocytes of Normal Skin vs. Benign Intradermal Naevus and Human Metastatic Melanoma Biopsies
  Pigment Cell Research, 2004
• An NF-κB-Specific Inhibitor, IκBα, Binds to and Inhibits Cyclin-Dependent Kinase 4
  Biochemistry, 2003
• The glucocorticoid receptor inhibits NFκB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain
  Genes & Development, 2000
• Aberrant rel/nfkb genes and activity in human cancer
  Oncogene, 1999
• Activators and target genes of Rel/NF-κB transcription factors
  Oncogene, 1999
• Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum Mol Genet 1998 May;7(5):941]
  Human Molecular Genetics, 1998
• Cancer Cell Cycles
  Science, 1996
• A Familial Syndrome of Pancreatic Cancer and Melanoma with a Mutation in theCDKN2Tumor-Suppressor Gene
  New England Journal of Medicine, 1995
• Mutations of the CDKN2/p16^INK4 gene in Australian melanoma kindreds
  Human Molecular Genetics, 1995
• A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
  Nature, 1993